𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endocannabinoids and liver disease

✍ Scribed by Wladimiro Jiménez

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
161 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endocannabinoids in liver disease
Endocannabinoids in liver disease
✍ Joseph Tam; Jie Liu; Bani Mukhopadhyay; Resat Cinar; Grzegorz Godlewski; George 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Endocannabinoids are lipid mediators of the same cannabinoid (CB) receptors that mediate the effects of marijuana. The endocannabinoid system (ECS) consists of CB receptors, endocannabinoids, and the enzymes involved in their biosynthesis and degradation, and it is present in both brain and peripher

Endocannabinoids
Endocannabinoids
✍ Harald S. Hansen; Gitte Petersen; Andreas Artmann; Andreas Nygaard Madsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB
Hepatic steatosis and endocannabinoids—D
Hepatic steatosis and endocannabinoids—Does it all happen within the liver?
✍ Hermann E. Wasmuth; Christian Trautwein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Diet-induced obesity is associated with fatty liver, insulin resistance, leptin resistance, and changes in plasma lipid profile. Endocannabinoids have been implicated in the development of these associated phenotypes, because mice deficient for the cannabinoid receptor CB(1) (CB1(؊/؊)) do not displa

Chronic liver disease and still's diseas
Chronic liver disease and still's disease
✍ JOHN R. P. Tesser; Edward J. Pisko; John W. Hartz; Michael E. Weinblatt 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

A patient with predominantly untreated Still's disease developed chronic necro-inflammatory liver disease over a 10-year period. Clinical and biochemical parameters of her liver disease were largely divergent from the systemic features of her Still's disease. Chronic liver disease has not been previ